awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38192656-077963F0-FE0C-4ADC-AFC4-8D765C81A9D7
Q38192656-077963F0-FE0C-4ADC-AFC4-8D765C81A9D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38192656-077963F0-FE0C-4ADC-AFC4-8D765C81A9D7
Update on B-cell targeted therapies for systemic lupus erythematosus.
P2860
Q38192656-077963F0-FE0C-4ADC-AFC4-8D765C81A9D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38192656-077963F0-FE0C-4ADC-AFC4-8D765C81A9D7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
30da4f74615ea16108ccb24fa1e1fd32cf1b7b34
P2860
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.